Biohit group half year financial report 2020
Biohit Oyj Half Year Financial Report 12 August 2020 at 9:30 am local time (EET) SUMMARY January-June 2020 ·Net sales EUR 3.0 million (EUR 5.0 million) · Net sales decreased by 40 % compared to H1/2019 · Operative EBITDA EUR -1.0 million (EUR +0.4 million) · Cash at the end of the period EUR 1.0 million (EUR 1.3 million 31 December 2019) · Fair value of Genetic Analysis AS investment EUR 0.8 million (EUR 3.7 million 31 December 2019) · Net sales from international operations 95.6 % (95.5 %) of total net sales · Equity ratio 81.0 % (83.9 % 31 December